PAHCHealthcareSmall-Cap

PHIBRO ANIMAL HEALTH CORP Insider Trading Activity

Every SEC Form 4 insider transaction reported for PHIBRO ANIMAL HEALTH CORP (PAHC), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are PAHC insiders buying or selling?

PHIBRO ANIMAL HEALTH CORP insiders reported 5 open-market buys ($752.8K) and 75 sells ($64.2M) across 80 Form 4 filings — a net selling position of $63.4M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jun 2, 2026)

Total Form 4 filings
80
SEC EDGAR
Insider filers
6
Insider buys (5)
$752.8K
Insider sells (75)
$64.2M

Insider sentiment

Net selling

Net insider flow of $63.4M in net selling. 1 insider buy in the last 90 days.

Recent PAHC insider transactions

DateInsiderRoleTypeSharesPriceValue
Jun 2, 2026Thomas E CorcoranDirectorPurchase10.0K$31.77$317.7K
May 7, 2026Jack BendheimPresident and CEOSale18.6K$54.61$1.0M
Apr 30, 2026Jack BendheimPresident and CEOSale21.1K$53.86$1.1M
Apr 23, 2026Jack BendheimPresident and CEOSale21.1K$54.79$1.2M
Apr 17, 2026Jack BendheimPresident and CEOSale21.1K$56.89$1.2M
Mar 31, 2026Jack BendheimPresident and CEOSale14.1K$53.75$756.8K
Mar 27, 2026Jack BendheimPresident and CEOSale21.1K$55.21$1.2M
Mar 19, 2026Jack BendheimPresident and CEOSale22.9K$52.40$1.2M
Mar 16, 2026Jack BendheimPresident and CEOSale5.3K$48.91$258.2K
Feb 27, 2026Jack BendheimPresident and CEOSale21.1K$52.27$1.1M
Feb 23, 2026Jack BendheimPresident and CEOSale14.1K$50.84$715.8K
Feb 19, 2026Jack BendheimPresident and CEOSale14.1K$51.68$727.6K
Feb 11, 2026Jack BendheimPresident and CEOSale72.2K$51.77$3.7M
Feb 9, 2026Jack BendheimPresident and CEOSale110.8K$48.38$5.4M
Feb 6, 2026Jack BendheimPresident and CEOSale13.2K$41.39$545.5K
Feb 2, 2026Jack BendheimPresident and CEOSale13.5K$40.11$540.0K
Jan 27, 2026Jack BendheimPresident and CEOSale1.2K$40.55$50.1K
Jan 23, 2026Jack BendheimPresident and CEOSale27.8K$41.82$1.2M
Jan 15, 2026Jack BendheimPresident and CEOSale14.1K$40.31$569.8K
Jan 13, 2026Jack BendheimPresident and CEOSale213$40.16$8.6K
Jan 8, 2026Jack BendheimPresident and CEOSale328$40.09$13.1K
Dec 10, 2025Jack BendheimPresident and CEOSale4.8K$40.10$192.8K
Dec 4, 2025Jack BendheimPresident and CEOSale7.0K$41.00$288.6K
Dec 2, 2025Jack BendheimPresident and CEOSale7.0K$42.10$296.4K
Nov 26, 2025Jack BendheimPresident and CEOSale12.3K$43.97$541.7K

Showing the 25 most recent of 80 Form 4 filings for PHIBRO ANIMAL HEALTH CORP.

Most active PAHC insiders

  • Jack Bendheim50 filings
  • BFI Co., LLC15 filings
  • Daniel M Bendheim6 filings
  • Thomas E Corcoran5 filings
  • Dean J Warras3 filings

Ask anything about PAHC insider activity

Use Trabud's AI agent to query PHIBRO ANIMAL HEALTH CORP's Form 4 history in plain English — "Show me PAHC CEO purchases this year" or compare it against any other ticker.

Open the AI agent

PAHC insider trading FAQ

Are PHIBRO ANIMAL HEALTH CORP insiders buying or selling?

Across 80 SEC Form 4 filings, PHIBRO ANIMAL HEALTH CORP (PAHC) insiders reported 5 open-market purchases totaling $752.8K and 75 sales totaling $64.2M. That is a net selling position of $63.4M.

How many insiders trade PAHC stock?

6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for PHIBRO ANIMAL HEALTH CORP. The most recent filing was accepted on Jun 2, 2026.

Where does Trabud get PAHC insider trading data?

All PAHC insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content